Neion Bio raises $23M Series A to scale its egg-based biologic manufacturing platform, which uses chickens to produce monoclonal antibodies and other proteins.
Neion extracts primordial germ cells from a fertilized egg in its genetic engineering process (Credit: Marco Figueroa)
June 11, 2026 07:00 AM EDT
PharmaManufacturing
Neion Bio lands $23M Series A to make proteins from chicken eggs
Anna Brown
NS/TX Industries Secures $10.5M in Funding To Scale Alt Protein Manufacturing Platform
Kiran Mazumdar-Shaw founded Immuneel Therapeutics raises Rs 100 crore in Series B Funding
The Spreading, Game-Changing Technology To Avoid Killing Male Chicks
Antogen Secures Seed Financing to Advance Next-Generation Immune Surveillance Diagnostics
NNB Nutrition Reports 33% Year-Over-Year Growth, Expands Strategic Investments and Industry Leadership in 2026
Prometheus raises $12 billion in capital for artificial engineers
Exclusive: The researchers who built AI-generated DNA just raised $50 million to reinvent biology | Fortune
In an early step towards artificial wombs, a biotech company claims it’s developed a “fully artificial” chicken egg.
A U.S. company said more than two dozen healthy baby chickens have hatched from an artificial egg platform it has developed in…
The biotech, co-founded by Sofinnova Partners and a former Sanofi immunology R&D head, is testing new biologics against common…
Colossal Biosciences has developed an artificial eggshell, marking significant progress in efforts to resurrect New Zealand's…
WASHINGTON, May 22 : A U.S. company said more than two dozen healthy baby chickens have hatched from an artificial egg platform…
Proliant Health & Biologicals Raises the Albumin Standard with AlbufreeDX: Consistent, Animal-Free Recombinant Human Albumin
